Financial Summary (All financials)
| In millions, except per share items | Mar-31-11 | Mar-31-10 | Mar-31-09 | Mar-31-08 |
| Revenues | 1.6 | 0.1 | 0.2 | 0.3 |
| Revenue growth | 1287.3% | -41.2% | -21.9% | |
| Cost of goods sold | 0.7 | 0.1 | 0.1 | 1.9 |
| Gross profit | 0.9 | 0.1 | 0.1 | -1.6 |
| Gross margin | 56.5% | 49.4% | 69.2% | -638.3% |
| Selling, general and administrative | 0.9 | 1.0 | | 1.2 |
| Sales and marketing | | | 0.1 | |
| Research and development | 1.7 | 1.6 | 0.1 | 0.3 |
| General and administrative | | | 1.0 | |
| EBIT | -5.3 | -15.9 | -1.8 | -5.6 |
| EBIT margin | -331.5% | -13823.5% | -914.3% | -2208.9% |
| Pre-tax income | -5.5 | -21.3 | 2.0 | 6.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | |
| Net income | -5.5 | -21.3 | -2.0 | -6.2 |
| Net margin | -342.9% | -18487.6% | -999.2% | -2477.0% |
| |
| Diluted EPS | $0.00 | ($0.02) | ($0.01) | ($0.08) |
| Shares outstanding (diluted) | 3,749.9 | 1,173.4 | 189.7 | 76.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|